Site and PI Engagement
Optimised protocol delivery
By providing onboarding, support and fine-tuned SOPs, we prioritise establishing a clear foundation for each site, enabling them to remain in control of their performance and understand the benefits our team brings to enhance trial delivery.
Improved
Site & PI oversight
Through clear, site-specific foundations, tailored procedures, and ongoing support and collaboration, we ensure effective oversight, reducing the burden on PIs and sites while enhancing operational efficiency.
Well-defined
& communicated
roles and SOPs
To empower PIs and site teams, we develop and communicate well-defined roles and SOPs, helping them operate efficiently, meet milestones, and reach their full potential in every trial.
Assured
quality and compliance
By integrating a robust QMS, we ensure consistent adherence to our service's quality standards, regulatory requirements, and trial-specific protocols, boosting site and PI confidence in DCTs.
Proven solution for site & PI engagement challenges
Traditional site engagement with DCT elements remains low due to perceived workload and lack of clarity of responsibilities. We work together with sites to remove burden and address engagement challenges. As an extended arm of the sites, we help our clients keep their trial with DCT elements on track.
“At FutureMeds @home, we share PIs’ commitment to patient safety and the integrity of the data. Their role demands unwavering accountability and confidence in the team, ensuring that every step of the trial is conducted with the utmost care and precision, fostering essential public trust in the process.”
Nicole Bohrmann
Director of Decentralized Operations
Site and PI benefits
Modernisation and Flexibility
The adoption of homecare visits represents a step toward a more modern clinical trial model, introducing more flexibility and efficiency while maintaining high-quality outcomes
Reduced
Patient Burden
By reducing the travel, logistical and personal burden on patients, clinical research sites can see higher recruitment and retention rates. This is especially significant for patients who would otherwise be unable to participate due to access issues.
Broader Enrollment
For hybrid trials with certain number of home visits, home nursing reduces the workload on a site team, enabling the enrollment of more participants and improving patient care during site visits
Real-World
Data Collection
Home nursing settings can offer insights into how a drug performs in real-world settings, which is valuable for regulatory approvals and market readiness.
Helping traditional sites pave the way for more inclusive, data-rich studies that better serve public health
Site and PI buy-in to reach full DCTs potential
FutureMeds @home’s deep understanding of the site business enables our teams to address unique site challenges and provide PIs and teams with the right tools, processes and solutions they need to reach their full potential
Track record of delivering quality & improving patient experience
FutureMeds @home is the only European independent DCT solution with over 12 years of experience that combines deep site business expertise, capabilities, quality & resource management to create winning business outcomes for performance-conscious clients
320+
DCT trials
delivered
140+
Indications
supported
12.5k+
Home visits
delivered
120+
Sponsors
supported
40+
CROs
supported
1,850+
Non-FutureMeds
sites supported
What our site-level partners say
Hear from Principal Investigators who trusted FutureMeds @home to boost their sites performance